LSE:BVXP (Bioventix PLC)
About BVXP
Bioventix develops high-affinity sheep monoclonal antibodies for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.
Bioventix PLC (LSE: BVXP) Latest News
Investing Articles
A FTSE 100 dividend growth stock I’d buy today and one top performer I’d consider selling
Investing Articles
Why I’d buy AstraZeneca plc over this soaring growth stock
Investing Articles
Should you buy this growth company after profits soar 40%?
Investing Articles
Why this small-cap stock could be the UK’s most exciting investment opportunity right now